The Cerebral Microvasculature in Schizophrenia: A Laser Capture Microdissection Study
Open Access
- 17 December 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (12), e3964
- https://doi.org/10.1371/journal.pone.0003964
Abstract
Previous studies of brain and peripheral tissues in schizophrenia patients have indicated impaired energy supply to the brain. A number of studies have also demonstrated dysfunction of the microvasculature in schizophrenia patients. Together these findings are consistent with a hypothesis of blood-brain barrier dysfunction in schizophrenia. In this study, we have investigated the cerebral vascular endothelium of schizophrenia patients at the level of transcriptomics. We used laser capture microdissection to isolate both microvascular endothelial cells and neurons from post mortem brain tissue from schizophrenia patients and healthy controls. RNA was isolated from these cell populations, amplified, and analysed using two independent microarray platforms, Affymetrix HG133plus2.0 GeneChips and CodeLink Whole Human Genome arrays. In the first instance, we used the dataset to compare the neuronal and endothelial data, in order to demonstrate that the predicted differences between cell types could be detected using this methodology. We then compared neuronal and endothelial data separately between schizophrenic subjects and controls. Analysis of the endothelial samples showed differences in gene expression between schizophrenics and controls which were reproducible in a second microarray platform. Functional profiling revealed that these changes were primarily found in genes relating to inflammatory processes. This study provides preliminary evidence of molecular alterations of the cerebral microvasculature in schizophrenia patients, suggestive of a hypo-inflammatory state in this tissue type. Further investigation of the blood-brain barrier in schizophrenia is warranted.This publication has 56 references indexed in Scilit:
- Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophreniaSchizophrenia Research, 2007
- Microarray amplification bias: loss of 30% differentially expressed genes due to long probe – poly(A)-tail distancesBMC Genomics, 2007
- Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease MechanismsPLOS ONE, 2007
- A rapid method for microarray cross platform comparisons using gene expression signaturesMolecular and Cellular Probes, 2007
- Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset PsychosisPLoS Medicine, 2006
- Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in SchizophreniaPLoS Medicine, 2006
- Abnormal changes of plasma acute phase proteins in schizophrenia and the relation between schizophrenia and haptoglobin (Hp) geneAmino Acids, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stressMolecular Psychiatry, 2004
- Vascular Genomics of the Human BrainJournal of Cerebral Blood Flow & Metabolism, 2002